Abbott India, INE358A01014

Abbott India stock enters Q2 results watch after profit rises 8.51 percent

Published on 10/07/2026 at 03:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

June 2026 PAT reached INR 428.52 crore and EPS was INR 201.66. The NSE quote was INR 26,115 on October 6, while the trading window closed ahead of Q2 FY27 results.

Abbott India, INE358A01014, Illustration mit AI erstellt.
Abbott India, INE358A01014, Illustration mit AI erstellt.

Abbott India stock (ISIN INE358A01014) was last at INR 26,115 on the NSE on October 6, 2026 at 3:30 p.m. IST, down 0.48 percent from the prior close. The stock is 3.90 percent above its 52-week low of INR 25,135 and 14.82 percent below its 52-week high of INR 30,655.

Q2 results move closer

The company entered the next reporting cycle after its trading window closed on October 1 for designated persons and their relatives, pending unaudited results for the quarter ended September 30, 2026. Tickertape reported the filing, which states that trading can resume 48 hours after the results are declared.

The upcoming print will be measured against the June 2026 quarter, when Abbott India delivered PAT of INR 428.52 crore and basic EPS of INR 201.66. Those figures give investors a clear operating baseline before the September-quarter numbers arrive.

Profit growth supports the baseline

According to The Economic Times, June 2026 PAT was INR 428.52 crore, compared with INR 394.93 crore in March 2026. That represents growth of 8.51 percent between the two reported quarters, while the net profit margin stood at 22.68 percent in June 2026.

The same June 2026 statement lists total income of INR 1,889.05 crore, compared with INR 1,785.10 crore in March 2026. Operating profit reached INR 578.12 crore, versus INR 537.37 crore in March, showing that the earnings comparison was accompanied by higher operating profit rather than a profit increase alone.

Valuation meets a lower range

Abbott India carried a market capitalization of INR 554.9 billion as of October 6, 2026, with 12,532 shares traded in the quoted session. The market value places the stock near the lower end of its 52-week band, although the price remains 3.90 percent above the yearly low.

The valuation question is therefore tied to the September-quarter outcome: June 2026 EPS of INR 201.66 provides the latest earnings anchor, while the October 6 price of INR 26,115 leaves the stock below its yearly high. The next result must show whether the June improvement continued into the quarter ending September 30.

Abbott India stock stays below yearly high

Abbott India stock was last at INR 26,115 on the NSE on October 6, 2026 at 3:30 p.m. IST. Its market capitalization was INR 554.9 billion on the same date, with the 52-week range at INR 25,135 to INR 30,655.

Abbott India stock facts

  • Company: Abbott India Limited
  • ISIN: INE358A01014
  • Ticker: ABBOTINDIA
  • Trading venue: NSE
  • Price (as of October 6, 2026, 3:30 p.m. IST): INR 26,115
  • Market capitalization: INR 554.9 billion (as of October 6, 2026)
  • 52-week range: INR 25,135-INR 30,655 (as of October 6, 2026)
  • Sector / Industry: Healthcare / Pharmaceuticals
  • Index membership: Nifty 500, Nifty Pharma

More news and analyses on Abbott India stock

Disclaimer...

en | INE358A01014 | ABBOTT INDIA | boerse | 70248716 | bgmi